TY - JOUR
T1 - Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel
AU - Katsoulakis, Evangelia
AU - Kudner, Randi
AU - Chapman, Christina
AU - Park, John
AU - Puckett, Lindsay
AU - Solanki, Abhi
AU - Kapoor, Rishabh
AU - Hagan, Michael
AU - Kelly, Maria
AU - Palta, Jatinder
AU - Tishler, Roy
AU - Hitchcock, Ying
AU - Chera, Bhisham
AU - Feygelman, Vladimir
AU - Walker, Gary
AU - Sher, David
AU - Kujundzic, Ksenija
AU - Wilson, Emily
AU - Dawes, Samantha
AU - Yom, Sue S.
AU - Harrison, Louis
N1 - Publisher Copyright:
© 2022
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Purpose: Safeguarding high-quality care using evidence-based radiation therapy for patients with head and neck cancer is crucial to improving oncologic outcomes, including survival and quality of life. Methods and Materials: The Veterans Administration (VA) National Radiation Oncology Program established the VA Radiation Oncology Quality Surveillance Program (VAROQS) to develop clinical quality measures (QM) in head and neck cancer. As part of the development of QM, the VA commissioned, along with the American Society for Radiation Oncology, a blue-ribbon panel comprising experts in head and neck cancer, to develop QM. Results: We describe the methods used to develop QM and the final consensus QM, as well as aspirational and surveillance QM, which capture all aspects of the continuum of patient care from initial patient work-up, radiation treatment planning and delivery, and follow-up care, as well as dose volume constraints. Conclusion: These QM are intended for use as part of ongoing quality surveillance for veterans receiving radiation therapy throughout the VA as well as outside the VA. They may also be used by the non-VA community as a basic measure of quality care for head and neck cancer patients receiving radiation.
AB - Purpose: Safeguarding high-quality care using evidence-based radiation therapy for patients with head and neck cancer is crucial to improving oncologic outcomes, including survival and quality of life. Methods and Materials: The Veterans Administration (VA) National Radiation Oncology Program established the VA Radiation Oncology Quality Surveillance Program (VAROQS) to develop clinical quality measures (QM) in head and neck cancer. As part of the development of QM, the VA commissioned, along with the American Society for Radiation Oncology, a blue-ribbon panel comprising experts in head and neck cancer, to develop QM. Results: We describe the methods used to develop QM and the final consensus QM, as well as aspirational and surveillance QM, which capture all aspects of the continuum of patient care from initial patient work-up, radiation treatment planning and delivery, and follow-up care, as well as dose volume constraints. Conclusion: These QM are intended for use as part of ongoing quality surveillance for veterans receiving radiation therapy throughout the VA as well as outside the VA. They may also be used by the non-VA community as a basic measure of quality care for head and neck cancer patients receiving radiation.
UR - http://www.scopus.com/inward/record.url?scp=85136151157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136151157&partnerID=8YFLogxK
U2 - 10.1016/j.prro.2022.05.009
DO - 10.1016/j.prro.2022.05.009
M3 - Article
C2 - 35667551
AN - SCOPUS:85136151157
SN - 1879-8500
VL - 12
SP - 409
EP - 423
JO - Practical Radiation Oncology
JF - Practical Radiation Oncology
IS - 5
ER -